Results 181 to 190 of about 30,567 (270)

A Novel Topical Emollient Plus for Canine Atopic Dermatitis: A Clinical Trial Assessing Efficacy and User Acceptance

Veterinary Dermatology, Volume 37, Issue 2, Page 293-305, April 2026.
Background: Canine atopic dermatitis (cAD) is a common, chronic skin condition characterised by epidermal barrier dysfunction, immune dysregulation and cutaneous dysbiosis. While “emollient plus” formulations are widely used in human atopic dermatitis, their role in cAD remains underexplored. Hypothesis/Objectives: To evaluate the clinical efficacy and
Beatriz Fernandes, António Caldeira Mendes, Susana Paula Alves, Vanessa Schmidt, Ana Filipa Bizarro, Marta Pinto, Hugo Pereira, Joana Marto, Ana Mafalda Lourenço   +8 more
wiley   +1 more source

Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma. [PDF]

Allergy
Woehlk C, Stranzl T, Contoli M, Freemantle N, Slaettanes AK, Larsen JR, Porsbjerg C, Fritzsching B.   +7 more
europepmc   +1 more source

Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study

Veterinary Dermatology, Volume 37, Issue 2, Page 306-318, April 2026.
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Petra Bizikova, Chigusa Matsumoto, Shoji Ogino, Toshihiro Tsukui, Kim Love, Marcy Murphy, Ina Herrmann   +6 more
wiley   +1 more source

Randomised, Double‐Blinded, Placebo‐Controlled Challenge Test With Single Food Items in Dogs With Atopic Dermatitis and Adverse Food Reactions

Veterinary Dermatology, Volume 37, Issue 2, Page 247-256, April 2026.
ABSTRACT Background Identification of offending foods in dogs with adverse food reactions is usually based on “deterioration” during open food challenges. Objectives To examine the placebo effect during double‐blinded, placebo‐controlled food challenges using a predefined set of criteria for relapse.
Evi I. Sofou, Elisa Samuel, Svetlina Aleksandrova, Manolis Chatzis, Manolis N. Saridomichelakis   +4 more
wiley   +1 more source

Distinct treatment response trajectories to allergen immunotherapy in allergic asthma and rhinitis: Insights from a multicenter study in routine clinical practice. [PDF]

World Allergy Organ J
Zhang P, Qin R, Zhang W, Yang Y, Li H, Dong X, He Y, Wang H, Chen Z, Chen L, Wu J, Bao Y, Tian M, Tan G, Ye J, Jin M, Liang Y, Xu K, Mao L, Lv Q, Zhang Y, Wang W, Li J.   +22 more
europepmc   +1 more source

Diagnosis of nasal allergy to the house dust mite [PDF]

, 1991
Berghaus, Alexander, Brunnee, T., Dokic, D., Jovanovic, S.   +3 more
core  

Report of the Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) in relation to the risk associated with the consumption of certain potentially allergenic foods

Food Risk Assess Europe, Volume 4, Issue 2, April 2026.
Abstract Food allergies are an important public health problem with an increasing prevalence in the population and have a significant impact on the lives of allergic patients and their families. The Scientific Committee of the Spanish Agency for Food Safety and Nutrition (AESAN) has reviewed and compiled the available information on those food ...
Araceli Díaz Perales, Irene Bretón Lesmes, Ángel José Gutiérrez Fernández, Gema Nieto Martínez, Silvia Pichardo Sánchez, María de Cortes Sánchez Mata, María Carmen Diéguez Pastor, Sonsoles Infante Herrero, María Ángeles Carlos Chillerón   +8 more
wiley   +1 more source

Evaluation of the Quality and Reliability of ChatGPT-4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality Assessment. [PDF]

Clin Transl Allergy
Cherrez-Ojeda I, Zuberbier T, Rodas-Valero G, Sanchez J, Rudenko M, Dramburg S, Demoly P, Caimmi D, Gómez RM, Ramon GD, Fouda GE, Quimby KR, Chong-Neto H, Llosa OC, Larco JI, Monge Ortega OP, Faytong-Haro M, Pfaar O, Bousquet J, Robles-Velasco K.   +19 more
europepmc   +1 more source

Loss of Tolerance in Long-Term Allergen Immunotherapy: A Case of Late-Onset Systemic Anaphylaxis. [PDF]

Cureus
Ehsani K, Mozafari K, Davoudpour M.
europepmc   +1 more source

Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies. [PDF]

Int J Mol Sci
Tamaș TP, Ciurariu E.
europepmc   +1 more source